Firialta v2

One move can change

the outcome¹

For your patients with CKD associated

with T2D, intervene now to deliver

dual cardiorenal risk reduction

Learn more >

Finerenone (Firialta^®) is indicated for treatment of
Chronic Kidney Disease (stage 3 and 4) with albuminuria
associated with type 2 diabetes (T2D)1

^{CKD=chronic kidney disease; T2D=type 2 diabetes.}

^{References: 1. Kerendia European Summary of Product Characteristics (SmPC); February 2023}

Secondary Navigation Menu

WSF OpenID Connect Login

One move can change

the outcome¹

For your patients with CKD associated

with T2D, intervene now to deliver

dual cardiorenal risk reduction

One move can change

the outcome1

For your patients with CKD associated

with T2D, intervene now to deliver

dual cardiorenal risk reduction

the outcome¹